-
ALSO READ
Coronavirus vaccine update: Mexico gets 1st doses of Chinese vaccine COVAX
Coronavirus vaccine update: UK, Russia to rollout vaccine from next week
Coronavirus vaccine update: China Covid vaccine gives quick immune response
Coronavirus vaccine update: 20 mn Americans may get vaccine by December-end
UK begins AstraZeneca Covid-19 vaccine rollout with dialysis patient
-
AstraZeneca says advanced trial data from a US study on its COVID vaccine shows it is 79 per cent effective.
The US study comprised 30,000 volunteers, 20,000 of whom were given the vaccine while the rest got dummy shots. The results were announed Monday.
The early findings from the US study are just one set of information AstraZeneca must submit to the Food and Drug Administration. An FDA advisory committee will publicly debate the evidence behind the shots before the agency decides whether to allow emergency use of the vaccine.
While the AstraZeneca vaccine has been authorized in more than 50 countries worldwide, scientists have been awaiting results of the US study in hopes it will clear up some of the confusion about just how well the shots really work.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
Dear Reader,
Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.
As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.
Support quality journalism and subscribe to Business Standard.
Digital Editor
RECOMMENDED FOR YOU